# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY

I Background Information:

A 510(k) Number K213875   
B Applicant Microgenics Corporation   
C Proprietary and Established Names DRI™ Tricyclics Serum Tox Assay   
D Regulatory Information

<table><tr><td rowspan=1 colspan=1>ProductCode(s)</td><td rowspan=1 colspan=1>Classification</td><td rowspan=1 colspan=1>RegulationSection</td><td rowspan=1 colspan=1>Panel</td></tr><tr><td rowspan=1 colspan=1>LFH</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>21 CFR 862.3910 -TricyclicAntidepressant DrugsTest System</td><td rowspan=1 colspan=1>TX - ClinicalToxicology</td></tr></table>

II Submission/Device Overview:

A Purpose for Submission: New device (assay)   
B Measurand: Nortriptyline   
C Type of Test: Qualitative/Semiquantitative - Enzymatic Immunoassay

# III Intended Use/Indications for Use:

A Intended Use(s):

See Indications for Use below.

# B Indication(s) for Use:

The DRI™ Tricyclics Serum Tox Assay is a homogenous enzyme immunoassay intended for the qualitative and/or semiquantitative determination of the presense of tricyclic antidepressants (TCAs) in human serum, plasma, or urine of patients at a cutoff concentration of $3 0 0 ~ \mathrm { { n g / m L } }$ in patients suspected of drug overdose.

The semi-quantitative mode is for the purpose of enabling laboratories to determine an appropriate dilution of the specimen for confirmation by a confirmatory method sych as Liquid Chromatography/Tandem Mass Spectrometry (LC-MS/MS) or permitting laboratories to establish quality control procedures.

The assay provides only a preliminary analytical test result. A more specific alternative chemical method must be used to obtain a confirmed analytical result. Liquid Chromatography/Tandem Mass Spectrometry (LC-MS/MS) is the preferred confirmatory method.

Clinical and professional judgment should be applied to any drug of abuse test result, particulary when preliminary positive results are used.

For In Vitro Diagnostic Use Only.

C Special Conditions for Use Statement(s):

Rx - For Prescription Use Only

D Special Instrument Requirements:

Architect c4000 Clinical Chemistry Analyzer

# IV Device/System Characteristics:

# A Device Description:

The DRI TM Tricyclics Serum Tox Assay is a homogeneous enzyme immunoassay used to detect tricyclic antidepressants in serum, plasma, or urine. The DRI TM Tricyclics Serum Tox assay is supplied as a two liquid reagent kit (Reagent A and Reagent E). They are bottled separately within the same kit, as described below:

• Antibody/Substrate Reagent (Reagent A) 1 bottle of $2 5 ~ \mathrm { m L }$ ( $\mathbf { 1 \times 2 5 \ m L }$ ): Contains polyclonal anti-tricyclics antibodies (sheep), glucose-6- phosphate (G6P), and nicotinamide adenine dinucleotide (NAD) in Tris buffer with sodium azide as a preservative.

• Enzyme Conjugate Reagent (Reagent E) 1 bottle of $\mathbf { 8 \ m L }$ $\mathbf { 1 \cdot 8 \ m L } )$ : Contains glucose-6- phosphate dehydrogenase (G6PDH) labeled with nortriptyline in Tris buffer with sodium azide as a preservative.

# B Principle of Operation:

The test is based on the competition of an enzyme, glucose-6-phosphate dehydrogenase (G6PDH), labeled-drug and the drug from the sample for a fixed amount of specific antibody binding sites. In the absence of the drug from the sample, the specific antibody binds the enzyme-labeled drug and the enzyme activity is inhibited. This phenomenon creates a direct relationship between drug concentration in the sample and the enzyme activity. The enzyme activity is determined spectrophotometrically at $3 4 0 \mathrm { n m }$ by measuring its ability to convert nicotinamide adenine dinucleotide (NAD) to NADH.

# V Substantial Equivalence Information:

A Predicate Device Name(s):

Tricyclic Serum Tox Eia Assay

B Predicate 510(k) Number(s):

K983268

C Comparison with Predicate(s):

<table><tr><td colspan="1" rowspan="1">Device &amp; PredicateDevice(s):</td><td colspan="1" rowspan="1">K213875</td><td colspan="1" rowspan="1">K983268</td></tr><tr><td colspan="1" rowspan="1">Device Trade Name</td><td colspan="1" rowspan="1">DRI TM TricyclicsSerum Tox Assay</td><td colspan="1" rowspan="1">Tricyclic Serum ToxEIA Assay</td></tr><tr><td colspan="1" rowspan="1">General DeviceCharacteristic Similarities</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Intended Use/IndicationsFor Use</td><td colspan="1" rowspan="1">Intended to be used forqualitative andsemiquantitativedetermination oftricyclic antidepressantsin serum, plasma orurine of patientssuspected of drugoverdose.</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Measurand</td><td colspan="1" rowspan="1">Nortriptyline</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Sample Matrix</td><td colspan="1" rowspan="1">Serum, Plasma, Urine</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Cut-Off</td><td colspan="1" rowspan="1">300 ng/mL</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">General DeviceCharacteristic Differences</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Antibody</td><td colspan="1" rowspan="1">Sheep polyclonalantibodies</td><td colspan="1" rowspan="1">Monoclonal antibodies</td></tr></table>

# VI Standards/Guidance Documents Referenced:

Evaluation of Precision of Quantitative Measurement Procedures; Approved Guideline– Third Edition. (Clinical and Laboratory Standards Institute (CLSI) EP05-A3). Interference Testing in Clinical Chemistry (CLSI EP07-ED3). Measurement Procedure Comparison and Bias Estimation Using Patient Samples (CLSI EP09c-ED3). Evaluation of Stability of In Vitro Diagnostic Reagents; Approved Guideline (CLSI EP25-A). • Assessment of Equivalence or Suitability of Specimen Types for Medical Laboratory Measurement Procedures. (CLSI EP35-ED1). User Protocol for Evaluation of Qualitative Test Performance Approved Guideline – Second Edition (CLSI EP12-A2).

# VII Performance Characteristics (if/when applicable):

# A Analytical Performance:

1. Precision/Reproducibility:

# Repeatability

Samples were prepared by spiking Nortriptyline into drug-free serum and drug-free urine at the cutoff as well as $2 5 \%$ , $50 \%$ , $7 5 \%$ , and $100 \%$ above and below the cutoff and tested in duplicate $( \mathrm { n } { = } 2 )$ twice per day for 20 days (total $\scriptstyle \mathrm { n = 8 0 }$ for each level), in both qualitative and semi-quantitative modes. The results are shown below.

Table #1 – Serum:   

<table><tr><td colspan="1" rowspan="2">SpikedConcentration(ng/mL)*</td><td colspan="1" rowspan="2">% ofCutoff</td><td colspan="5" rowspan="1">Total Precision (n=80)  Serum</td></tr><tr><td colspan="1" rowspan="1"># ofDeterminants</td><td colspan="1" rowspan="1">QualitativeImmunoassayResults(Negative/Positive</td><td colspan="1" rowspan="1">Semi-quantitativeImmunoassayResults(Negative/Positive)</td><td colspan="1" rowspan="1">Semi-quantitativeSD results</td><td colspan="1" rowspan="1">Semi-quantitativeCV% results</td></tr><tr><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">-100</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">80/0</td><td colspan="1" rowspan="1">80/0</td><td colspan="1" rowspan="1">N/A</td><td colspan="1" rowspan="1">N/A</td></tr><tr><td colspan="1" rowspan="1">75</td><td colspan="1" rowspan="1">-75</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">80/0</td><td colspan="1" rowspan="1">80/0</td><td colspan="1" rowspan="1">4.40</td><td colspan="1" rowspan="1">5.36</td></tr><tr><td colspan="1" rowspan="1">150</td><td colspan="1" rowspan="1">-50</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">80/0</td><td colspan="1" rowspan="1">80/0</td><td colspan="1" rowspan="1">4.19</td><td colspan="1" rowspan="1">2.42</td></tr><tr><td colspan="1" rowspan="1">225</td><td colspan="1" rowspan="1">-25</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">80/0</td><td colspan="1" rowspan="1">80/0</td><td colspan="1" rowspan="1">4.22</td><td colspan="1" rowspan="1">1.68</td></tr><tr><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">10/70</td><td colspan="1" rowspan="1">19/61</td><td colspan="1" rowspan="1">17.29</td><td colspan="1" rowspan="1">5.34</td></tr><tr><td colspan="1" rowspan="2">SpikedConcentration(ng/mL)*</td><td colspan="1" rowspan="2">% ofCutoff</td><td colspan="5" rowspan="1">Total Precision (n=80) - Serum</td></tr><tr><td colspan="1" rowspan="1"># ofDeterminants</td><td colspan="1" rowspan="1">QualitativeImmunoassayResults(Negative/Positive</td><td colspan="1" rowspan="1">Semi-quantitativeImmunoassayResults(Negative/Positive</td><td colspan="1" rowspan="1">Semi-quantitativeSD results</td><td colspan="1" rowspan="1">Semi-quantitativeCV% results</td></tr><tr><td colspan="1" rowspan="1">375</td><td colspan="1" rowspan="1">+25</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">0/80</td><td colspan="1" rowspan="1">0/80</td><td colspan="1" rowspan="1">16.59</td><td colspan="1" rowspan="1">3.92</td></tr><tr><td colspan="1" rowspan="1">450</td><td colspan="1" rowspan="1">+50</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">0/80</td><td colspan="1" rowspan="1">0/80</td><td colspan="1" rowspan="1">19.15</td><td colspan="1" rowspan="1">3.94</td></tr><tr><td colspan="1" rowspan="1">525</td><td colspan="1" rowspan="1">+75</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">0/80</td><td colspan="1" rowspan="1">0/80</td><td colspan="1" rowspan="1">47.37</td><td colspan="1" rowspan="1">8.25</td></tr><tr><td colspan="1" rowspan="1">600</td><td colspan="1" rowspan="1">+100</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">0/80</td><td colspan="1" rowspan="1">0/80</td><td colspan="1" rowspan="1">43.10</td><td colspan="1" rowspan="1">6.28</td></tr></table>

\*Approximate concentrations

Table #2 – Urine:   

<table><tr><td rowspan=2 colspan=1>SpikedConcentration(ng/mL)*</td><td rowspan=2 colspan=1>% ofCutoff</td><td rowspan=1 colspan=5>Total Precision (n=80) - Urine</td></tr><tr><td rowspan=1 colspan=1># ofDeterminantsI</td><td rowspan=1 colspan=1>QualitativeImmunoassayResults(Negative/Positive)</td><td rowspan=1 colspan=1>Semi-quantitativeImmunoassayResults(Negative/Positive)</td><td rowspan=1 colspan=1>Semi-quantitativeSD results</td><td rowspan=1 colspan=1>Semi-quantitativeCV% results</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>-100</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80/0</td><td rowspan=1 colspan=1>80/0</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>N/A</td></tr><tr><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>-75</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80/0</td><td rowspan=1 colspan=1>80/0</td><td rowspan=1 colspan=1>4.62</td><td rowspan=1 colspan=1>5.96</td></tr><tr><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>-50</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80/0</td><td rowspan=1 colspan=1>80/0</td><td rowspan=1 colspan=1>7.19</td><td rowspan=1 colspan=1>4.45</td></tr><tr><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>-25</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80/0</td><td rowspan=1 colspan=1>80/0</td><td rowspan=1 colspan=1>9.62</td><td rowspan=1 colspan=1>4.08</td></tr><tr><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>68/12</td><td rowspan=1 colspan=1>73/7</td><td rowspan=1 colspan=1>11.04</td><td rowspan=1 colspan=1>3.75</td></tr><tr><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>+25</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>0/80</td><td rowspan=1 colspan=1>0/80</td><td rowspan=1 colspan=1>24.41</td><td rowspan=1 colspan=1>6.12</td></tr><tr><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>+50</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>0/80</td><td rowspan=1 colspan=1>0/80</td><td rowspan=1 colspan=1>18.65</td><td rowspan=1 colspan=1>4.13</td></tr><tr><td rowspan=1 colspan=1>525</td><td rowspan=1 colspan=1>+75</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>0/80</td><td rowspan=1 colspan=1>0/80</td><td rowspan=1 colspan=1>46.66</td><td rowspan=1 colspan=1>8.89</td></tr><tr><td rowspan=1 colspan=1>600</td><td rowspan=1 colspan=1>+100</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>0/80</td><td rowspan=1 colspan=1>0/80</td><td rowspan=1 colspan=1>45.15</td><td rowspan=1 colspan=1>7.63</td></tr></table>

\*Approximate concentrations

# Reproducibility:

Samples were prepared by spiking Nortriptyline into drug-free serum and drug-free urine at the cutoff as well as at $2 5 \%$ , $50 \%$ , $7 5 \%$ , and $100 \%$ above and below the cutoff. Spiked samples were tested as 1 run per day, 5 replicates per run for a total of 5 days in qualitative and semi-quantitative modes on 3 different instruments of the same model. The results of the reproducibility study are shown below:

<table><tr><td rowspan=2 colspan=1>SpikedConcentration(ng/mL)*</td><td rowspan=2 colspan=1>% ofCutoff</td><td rowspan=1 colspan=5>Total Precision (n=75) - Serum</td></tr><tr><td rowspan=1 colspan=1># ofDeterminantsImmunoassay</td><td rowspan=1 colspan=1>QualitativeDeterminantsImmunoassayResults(Negative/Positive)</td><td rowspan=1 colspan=1>Semi-quantitativeImmunoassayResults(Negative/Positive)</td><td rowspan=1 colspan=1>Semi-quantitativeSD results</td><td rowspan=1 colspan=1>Semi-quantitativeCV% results</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>-100</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>75/0</td><td rowspan=1 colspan=1>75/0</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>N/A</td></tr><tr><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>-75</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>75/0</td><td rowspan=1 colspan=1>75/0</td><td rowspan=1 colspan=1>5.26</td><td rowspan=1 colspan=1>6.66</td></tr><tr><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>-50</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>75/0</td><td rowspan=1 colspan=1>75/0</td><td rowspan=1 colspan=1>4.00</td><td rowspan=1 colspan=1>2.39</td></tr><tr><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>-25</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>75/0</td><td rowspan=1 colspan=1>75/0</td><td rowspan=1 colspan=1>4.36</td><td rowspan=1 colspan=1>1.76</td></tr><tr><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>30/45</td><td rowspan=1 colspan=1>29/46</td><td rowspan=1 colspan=1>19.24</td><td rowspan=1 colspan=1>6.11</td></tr><tr><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>+25</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0/75</td><td rowspan=1 colspan=1>0/75</td><td rowspan=1 colspan=1>22.23</td><td rowspan=1 colspan=1>5.40</td></tr><tr><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>+50</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0/75</td><td rowspan=1 colspan=1>0/75</td><td rowspan=1 colspan=1>21.06</td><td rowspan=1 colspan=1>4.41</td></tr><tr><td rowspan=1 colspan=1>525</td><td rowspan=1 colspan=1>+75</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0/75</td><td rowspan=1 colspan=1>0/75</td><td rowspan=1 colspan=1>43.78</td><td rowspan=1 colspan=1>7.87</td></tr><tr><td rowspan=1 colspan=1>600</td><td rowspan=1 colspan=1>+100</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0/75</td><td rowspan=1 colspan=1>0/75</td><td rowspan=1 colspan=1>43.77</td><td rowspan=1 colspan=1>6.54</td></tr></table>

\*Approximate concentrations

Table #4 – Urine:   

<table><tr><td rowspan=2 colspan=1>SpikedConcentration(ng/mL)*</td><td rowspan=2 colspan=1>% ofCutoff</td><td rowspan=1 colspan=5>Total Precision (n=75) - Urine</td></tr><tr><td rowspan=1 colspan=1># ofDeterminantsImmunoassay</td><td rowspan=1 colspan=1>QualitativeDeterminantsImmunoassayResults(Negative/Positive</td><td rowspan=1 colspan=1>Semi-quantitativeImmunoassayResults (Negative/Positive)</td><td rowspan=1 colspan=1>Semi-quantitativeSD results</td><td rowspan=1 colspan=1>Semi-quantitativeCV% results</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>-100</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>75/0</td><td rowspan=1 colspan=1>75/0</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>N/A</td></tr><tr><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>-75</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>75/0</td><td rowspan=1 colspan=1>75/0</td><td rowspan=1 colspan=1>3.34</td><td rowspan=1 colspan=1>4.30</td></tr><tr><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>-50</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>75/0</td><td rowspan=1 colspan=1>75/0</td><td rowspan=1 colspan=1>4.60</td><td rowspan=1 colspan=1>2.82</td></tr><tr><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>-25</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>75/0</td><td rowspan=1 colspan=1>75/0</td><td rowspan=1 colspan=1>6.90</td><td rowspan=1 colspan=1>2.86</td></tr><tr><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>61/14</td><td rowspan=1 colspan=1>66/9</td><td rowspan=1 colspan=1>12.05</td><td rowspan=1 colspan=1>4.01</td></tr><tr><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>+25</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0/75</td><td rowspan=1 colspan=1>0/75</td><td rowspan=1 colspan=1>23.21</td><td rowspan=1 colspan=1>5.85</td></tr><tr><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>+50</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0/75</td><td rowspan=1 colspan=1>0/75</td><td rowspan=1 colspan=1>23.96</td><td rowspan=1 colspan=1>5.28</td></tr><tr><td rowspan=1 colspan=1>525</td><td rowspan=1 colspan=1>+75</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0/75</td><td rowspan=1 colspan=1>0/75</td><td rowspan=1 colspan=1>39.74</td><td rowspan=1 colspan=1>7.73</td></tr><tr><td rowspan=1 colspan=1>600</td><td rowspan=1 colspan=1>+100</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0/75</td><td rowspan=1 colspan=1>0/75</td><td rowspan=1 colspan=1>42.36</td><td rowspan=1 colspan=1>7.86</td></tr></table>

\*Approximate concentrations

# 2. Linearity:

Drug-free serum or drug-free urine was spiked with Nortriptyline to the concentration of the high calibrator level and diluted with drug-free serum or drug-free urine to generate 9 intermediate levels. Five (5) replicates of each sample using one (1) lot of reagents, calibrators, and controls were run in semi-quantitative mode and the average was used to determine percent recovery compared to the expected target value.

Table #5: Linearity Results Table  

<table><tr><td rowspan=2 colspan=1>ExpectedConcentration(ng/mL)</td><td rowspan=2 colspan=1>Observed MeanConcentration forSerum (ng/mL)</td><td rowspan=2 colspan=1>Observed MeanConcentration forUrine (ng/mL)</td><td rowspan=1 colspan=2>Range ofRecovery (%)</td></tr><tr><td rowspan=1 colspan=1>Serum</td><td rowspan=1 colspan=1>Urine</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>NA</td><td rowspan=1 colspan=1>NA</td></tr><tr><td rowspan=1 colspan=1>125</td><td rowspan=1 colspan=1>121</td><td rowspan=1 colspan=1>148</td><td rowspan=3 colspan=1></td><td rowspan=8 colspan=1>94-118*</td></tr><tr><td rowspan=1 colspan=1>250</td><td rowspan=1 colspan=1>242</td><td rowspan=1 colspan=1>271</td></tr><tr><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>385</td><td rowspan=1 colspan=1>383</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>479</td><td rowspan=1 colspan=1>470</td><td rowspan=5 colspan=1>96-115*</td></tr><tr><td rowspan=1 colspan=1>625</td><td rowspan=1 colspan=1>720</td><td rowspan=1 colspan=1>620</td></tr><tr><td rowspan=1 colspan=1>750</td><td rowspan=1 colspan=1>839</td><td rowspan=1 colspan=1>741</td></tr><tr><td rowspan=1 colspan=1>875</td><td rowspan=1 colspan=1>913</td><td rowspan=1 colspan=1>838</td></tr><tr><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>1046</td><td rowspan=1 colspan=1>946</td></tr></table>

\*Excluding the observed mean concentration at the $I ^ { s t }$ Level $( \theta n g / m L )$ .

# 3. Analytical Specificity/Interference:

The cross-reactivity of tricyclic antidepressants as well as their metabolites was evaluated by adding known amounts of each compound to drug-free serum and urine. The specificity (cross-reactivity) study was performed using one lot of reagents, calibrators and controls in both qualitative and semi-quantitative modes. Two (2) replicates of each cross-reactant sample were run in qualitative and semi-quantitative modes on the Architect $\mathsf { c 4 0 0 0 }$ clinical chemistry analyzer. Percent cross-reactivity was calculated as (cut-off concentration / lowest concentration observed that provides a reliably positive result) $\textbf { x } 1 0 0$ . Results are summarized in tables $\# 6$ and #7 below:

Table #6: Cross Reactivity of Tricyclic antidepressants and structurally related compounds - Serum   

<table><tr><td colspan="1" rowspan="1">Tricyclic Antidepressants &amp; Structurallyrelated compounds</td><td colspan="1" rowspan="1">Concentration tested(ng/mL)</td><td colspan="1" rowspan="1">Cross-reactivity(%)</td></tr><tr><td colspan="1" rowspan="1">2 -Hydroxy Imipramine</td><td colspan="1" rowspan="1">1,300</td><td colspan="1" rowspan="1">23.1</td></tr><tr><td colspan="1" rowspan="1">7-Hydroxy Quetiapine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">7-Hydroxy Amoxapine solution</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">8-Hydroxy Amoxapine solution</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">10-Hydroxyamitriptyline</td><td colspan="1" rowspan="1">1,000</td><td colspan="1" rowspan="1">30.0</td></tr><tr><td colspan="1" rowspan="1">Alimemazine</td><td colspan="1" rowspan="1">12,000</td><td colspan="1" rowspan="1">2.5</td></tr><tr><td colspan="1" rowspan="1">Amitriptyline</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">85.7</td></tr><tr><td colspan="1" rowspan="1">Amoxapine</td><td colspan="1" rowspan="1">125,000</td><td colspan="1" rowspan="1">0.2</td></tr><tr><td colspan="1" rowspan="1">Blonanserin</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">Chlorpromazine</td><td colspan="1" rowspan="1">525</td><td colspan="1" rowspan="1">57.1</td></tr><tr><td colspan="1" rowspan="1">Clomipramine</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">100.0</td></tr><tr><td colspan="1" rowspan="1">Clozapine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">Cyclobenzaprine</td><td colspan="1" rowspan="1">450</td><td colspan="1" rowspan="1">66.7</td></tr><tr><td colspan="1" rowspan="1">Desipramine</td><td colspan="1" rowspan="1">250</td><td colspan="1" rowspan="1">120.0</td></tr><tr><td colspan="1" rowspan="1">Desloratadine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">Diphenhydramine</td><td colspan="1" rowspan="1">60,000</td><td colspan="1" rowspan="1">0.5</td></tr><tr><td colspan="1" rowspan="1">Dosulepin</td><td colspan="1" rowspan="1">475</td><td colspan="1" rowspan="1">63.2</td></tr><tr><td colspan="1" rowspan="1">Doxepin</td><td colspan="1" rowspan="1">600</td><td colspan="1" rowspan="1">50.0</td></tr><tr><td colspan="1" rowspan="1">Fluoxentine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">Fluphenazine</td><td colspan="1" rowspan="1">2,000</td><td colspan="1" rowspan="1">15.0</td></tr><tr><td colspan="1" rowspan="1">Haloperidol</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">Imipramine</td><td colspan="1" rowspan="1">190</td><td colspan="1" rowspan="1">157.9</td></tr><tr><td colspan="1" rowspan="1">Loratadine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">Lofepramine</td><td colspan="1" rowspan="1">430</td><td colspan="1" rowspan="1">69.8</td></tr><tr><td colspan="1" rowspan="1">Loxapine Succinate</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">Maprotiline</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">0.3</td></tr><tr><td colspan="1" rowspan="1">Mianserin</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">Mirtazapine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">N-Desmethylclozapine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">N-Desmethyltrimpramine</td><td colspan="1" rowspan="1">350</td><td colspan="1" rowspan="1">85.7</td></tr><tr><td colspan="1" rowspan="1">NefazodoneN-Desmethylmirtazapine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">Nefazodone N-Desmethylmirtazapine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">Norclomipramine Hydrochloride</td><td colspan="1" rowspan="1">375</td><td colspan="1" rowspan="1">80.0</td></tr><tr><td colspan="1" rowspan="1">Nordoxepin Hydrochloride</td><td colspan="1" rowspan="1">1,750</td><td colspan="1" rowspan="1">17.1</td></tr><tr><td colspan="1" rowspan="1">Normaprotiline</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">0.3</td></tr><tr><td colspan="1" rowspan="1">Nortriptyline</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">100.0</td></tr><tr><td colspan="1" rowspan="1">Olanzapine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">Opipramol HCL</td><td colspan="1" rowspan="1">400</td><td colspan="1" rowspan="1">85.7</td></tr><tr><td colspan="1" rowspan="1">Praoxetine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">Perphenazine</td><td colspan="1" rowspan="1">450</td><td colspan="1" rowspan="1">66.7</td></tr><tr><td colspan="1" rowspan="1">Phenoxybenzanmine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">Promazine</td><td colspan="1" rowspan="1">400</td><td colspan="1" rowspan="1">75.0</td></tr><tr><td colspan="1" rowspan="1">Promethazine</td><td colspan="1" rowspan="1">20,000</td><td colspan="1" rowspan="1">1.5</td></tr><tr><td colspan="1" rowspan="1">Protriptyline</td><td colspan="1" rowspan="1">450</td><td colspan="1" rowspan="1">66.7</td></tr><tr><td colspan="1" rowspan="1">Quetiapine Fumarate</td><td colspan="1" rowspan="1">50,000</td><td colspan="1" rowspan="1">0.6</td></tr><tr><td colspan="1" rowspan="1">Risperidone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">Sertraline</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">Thioridazine</td><td colspan="1" rowspan="1">6,000</td><td colspan="1" rowspan="1">5.0</td></tr><tr><td colspan="1" rowspan="1">Thiothixene</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">Tianeptine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">Trazodone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">0.3</td></tr><tr><td colspan="1" rowspan="1">Trimipramine</td><td colspan="1" rowspan="1">390</td><td colspan="1" rowspan="1">76.9</td></tr><tr><td colspan="1" rowspan="1">Ziprasidone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr></table>

Table #7: Cross Reactivity of Tricyclic antidepressants and structurally related compounds - Urine   

<table><tr><td colspan="1" rowspan="1">Tricyclic Antidepressants &amp; Structurallyrelated compounds</td><td colspan="1" rowspan="1">Concentration tested(ng/mL)</td><td colspan="1" rowspan="1">Cross-reactivity(%)</td></tr><tr><td colspan="1" rowspan="1">2 -Hydroxy Imipramine</td><td colspan="1" rowspan="1">1,000</td><td colspan="1" rowspan="1">30.0</td></tr><tr><td colspan="1" rowspan="1">7-Hydroxy Quetiapine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">7-Hydroxy Amoxapine solution</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">8-Hydroxy Amoxapine solution</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">10-Hydroxyamitriptyline</td><td colspan="1" rowspan="1">1,000</td><td colspan="1" rowspan="1">30.0</td></tr><tr><td colspan="1" rowspan="1">Alimemazine</td><td colspan="1" rowspan="1">12,000</td><td colspan="1" rowspan="1">2.5</td></tr><tr><td colspan="1" rowspan="1">Amitriptyline</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">Amoxapine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">0.2</td></tr><tr><td colspan="1" rowspan="1">Blonanserin</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">Chlorpromazine</td><td colspan="1" rowspan="1">600</td><td colspan="1" rowspan="1">50.0</td></tr><tr><td colspan="1" rowspan="1">Clomipramine</td><td colspan="1" rowspan="1">350</td><td colspan="1" rowspan="1">85.7</td></tr><tr><td colspan="1" rowspan="1">Clozapine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">Cyclobenzaprine</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">60.0</td></tr><tr><td colspan="1" rowspan="1">Desipramine</td><td colspan="1" rowspan="1">250</td><td colspan="1" rowspan="1">120</td></tr><tr><td colspan="1" rowspan="1">Desloratadine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">Diphenhydramine</td><td colspan="1" rowspan="1">30,000</td><td colspan="1" rowspan="1">1.0</td></tr><tr><td colspan="1" rowspan="1">Dosulepin</td><td colspan="1" rowspan="1">550</td><td colspan="1" rowspan="1">54.5</td></tr><tr><td colspan="1" rowspan="1">Doxepin</td><td colspan="1" rowspan="1">600</td><td colspan="1" rowspan="1">50.0</td></tr><tr><td colspan="1" rowspan="1">Fluoxentine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">Fluphenazine</td><td colspan="1" rowspan="1">2,000</td><td colspan="1" rowspan="1">15.0</td></tr><tr><td colspan="1" rowspan="1">Haloperidol</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">Imipramine</td><td colspan="1" rowspan="1">250</td><td colspan="1" rowspan="1">120.0</td></tr><tr><td colspan="1" rowspan="1">Loratadine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">Lofepramine</td><td colspan="1" rowspan="1">460</td><td colspan="1" rowspan="1">65.2</td></tr><tr><td colspan="1" rowspan="1">Loxapine Succinate</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">0.3</td></tr><tr><td colspan="1" rowspan="1">Maprotiline</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">0.3</td></tr><tr><td colspan="1" rowspan="1">Mianserin</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">Mirtazapine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">N-Desmethylclozapine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">N-Desmethyltrimpramine</td><td colspan="1" rowspan="1">325</td><td colspan="1" rowspan="1">92.3</td></tr><tr><td colspan="1" rowspan="1">N-Desmethylmirtazapine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">Nefazodone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">Norclomipramine Hydrochloride</td><td colspan="1" rowspan="1">450</td><td colspan="1" rowspan="1">66.7</td></tr><tr><td colspan="1" rowspan="1">Nordoxepin Hydrochloride</td><td colspan="1" rowspan="1">1,750</td><td colspan="1" rowspan="1">17.1</td></tr><tr><td colspan="1" rowspan="1">Normaprotiline</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">0.3</td></tr><tr><td colspan="1" rowspan="1">Nortriptyline</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">100.0</td></tr><tr><td colspan="1" rowspan="1">Olanzapine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">Opipramol HCL</td><td colspan="1" rowspan="1">350</td><td colspan="1" rowspan="1">85.7</td></tr><tr><td colspan="1" rowspan="1">Praoxetine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">Perphenazine</td><td colspan="1" rowspan="1">650</td><td colspan="1" rowspan="1">46.2</td></tr><tr><td colspan="1" rowspan="1">Phenoxybenzanmine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">Promazine</td><td colspan="1" rowspan="1">410</td><td colspan="1" rowspan="1">73.2</td></tr><tr><td colspan="1" rowspan="1">Promethazine</td><td colspan="1" rowspan="1">15,000</td><td colspan="1" rowspan="1">2.0</td></tr><tr><td colspan="1" rowspan="1">Protriptyline</td><td colspan="1" rowspan="1">550</td><td colspan="1" rowspan="1">54.6</td></tr><tr><td colspan="1" rowspan="1">Quetiapine Fumarate</td><td colspan="1" rowspan="1">45,000</td><td colspan="1" rowspan="1">0.7</td></tr><tr><td colspan="1" rowspan="1">Risperidone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">Sertraline</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">Thioridazine</td><td colspan="1" rowspan="1">4,000</td><td colspan="1" rowspan="1">7.5</td></tr><tr><td colspan="1" rowspan="1">Thiothixene</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">Tianeptine</td><td colspan="1" rowspan="1">90,000</td><td colspan="1" rowspan="1">0.33</td></tr><tr><td colspan="1" rowspan="1">Trazodone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr><tr><td colspan="1" rowspan="1">Trimipramine</td><td colspan="1" rowspan="1">400</td><td colspan="1" rowspan="1">75</td></tr><tr><td colspan="1" rowspan="1">Ziprasidone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">&lt;0.3</td></tr></table>

A specificity study of structurally unrelated compounds/or concurrently used drugs was evaluated by adding known amounts of each compound to low and high controls (225 and $3 7 5 ~ \mathrm { { n g / m L } ) }$ ) in serum and urine. The study was performed using one lot of reagents, calibrators and controls in both qualitative and semi-quantitative modes. Two (2) replicates of each cross-reactant sample were run in qualitative and semi-quantitative modes on the Architect $\mathtt { c 4 0 0 0 }$ clinical chemistry analyzer. Results are summarized in tables $\# 8$ and #9 below:

Table #8: Structurally unrelated compounds – Serum   

<table><tr><td colspan="1" rowspan="2">Structurally unrelated compounds</td><td colspan="3" rowspan="1">Serum</td></tr><tr><td colspan="1" rowspan="1">Concentrationtested (ng/mL)</td><td colspan="1" rowspan="1">Low Control -25% of cutoff(225 ng/mL)</td><td colspan="1" rowspan="1">High Control+25% of cutoff(375 ng/mL)</td></tr><tr><td colspan="1" rowspan="1">11-nor-Δ9-THC-COOH (11-Nor-9-carboxy-THC)</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">6-Acetyl morphine</td><td colspan="1" rowspan="1">75,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Acetaminophen</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Acetylsalicylic acid</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Amisulpride</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Amoxicillin</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Amphetamine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Benzotropine Methane Sulfonate</td><td colspan="1" rowspan="1">3,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Benzoylecgonine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Brompheniramine</td><td colspan="1" rowspan="1">3,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Caffeine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Carbamazepine</td><td colspan="1" rowspan="1">3,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Carbamazepine Epoxide</td><td colspan="1" rowspan="1">10,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Chloroquine Phosphate</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Cimetidine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Cocaine</td><td colspan="1" rowspan="1">75,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Codeine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Dextromethorphan</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Diacetylmorphine (Heroin)</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Digoxin</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Dihydrocodeine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">EDDP Perchlorate</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">EMDP-HCL</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Fentanyl</td><td colspan="1" rowspan="1">25,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Glutethimide</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Hydrocodone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Hydrocortisone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Hydromorphone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Hydroxyzine</td><td colspan="1" rowspan="1">3,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Ibuprofen</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Levorphanol-D3</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Meperidine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Methadone</td><td colspan="1" rowspan="1">3,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Methamphetamine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Methaqualone</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Methsuximide</td><td colspan="1" rowspan="1">75,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Methylphenidate</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Morphine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Morphine-3β-glucuronide</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Morphine-6β-glucuronide</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Nalbuphine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Nalorphine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Naloxone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Naltrexone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Naproxen</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Norcodeine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Nordiazepam</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Norethindrone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Norhydrocone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Noroxycodone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Noroxymorphone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Norpropoxyphene</td><td colspan="1" rowspan="1">75,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Oxaprozin</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Oxazepam</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Oxycodone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Oxymorphone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">PCP</td><td colspan="1" rowspan="1">50,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Phenobarbital</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Phenytoin</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Primidone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Procyclidine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Propoxyphene</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Secobarbital</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Tapentadol</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Temazepam</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Triprolidine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Valproic Acid</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Venlafaxine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Verapamil</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr></table>

Table #9: Structurally unrelated compounds – Urine:   

<table><tr><td colspan="1" rowspan="2">Structurally unrelated compounds</td><td colspan="3" rowspan="1">Urine</td></tr><tr><td colspan="1" rowspan="1">Concentrationtested (ng/mL)</td><td colspan="1" rowspan="1">Low Control -25% of cutoff(225 ng/mL)</td><td colspan="1" rowspan="1">High Control+25% of cutoff(375 ng/mL)</td></tr><tr><td colspan="1" rowspan="1">11-nor-Δ9-THC-COOH (11-Nor-9-carboxy-THC)</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">6-Acetyl morphine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Acetaminophen</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Acetylsalicylic acid</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Amisulpride</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Amoxicillin</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Amphetamine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Benzotropine Methane Sulfonate</td><td colspan="1" rowspan="1">7,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Benzoylecgonine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Brompheniramine</td><td colspan="1" rowspan="1">5,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Caffeine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Carbamazepine</td><td colspan="1" rowspan="1">5,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Carbamazepine Epoxide</td><td colspan="1" rowspan="1">30,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Chloroquine Phosphate</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Cimetidine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Cocaine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Codeine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Dextromethorphan</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Diacetylmorphine (Heroin)</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Digoxin</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Dihydrocodeine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">EDDP Perchlorate</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">EMDP-HCL</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Fentanyl</td><td colspan="1" rowspan="1">25,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Glutethimide</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Hydrocodone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Hydrocortisone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Hydromorphone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Hydroxyzine</td><td colspan="1" rowspan="1">5,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Ibuprofen</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Levorphanol-D3</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Levothyroxine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Meperidine</td><td colspan="1" rowspan="1">25,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Methadone</td><td colspan="1" rowspan="1">75,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Methamphetamine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Methaqualone</td><td colspan="1" rowspan="1">1,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Methsuximide</td><td colspan="1" rowspan="1">75,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Methylphenidate</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Morphine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Morphine-3β-glucuronide</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Morphine-6β-glucuronide</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Nalbuphine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Nalorphine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Naloxone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Naltrexone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Naproxen</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Norcodeine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Nordiazepam</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Norethindrone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Norhydrocone</td><td colspan="1" rowspan="1">75,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Noroxycodone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Noroxymorphone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Norpropoxyphene</td><td colspan="1" rowspan="1">75,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Oxaprozin</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Oxazepam</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Oxycodone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Oxymorphone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">PCP</td><td colspan="1" rowspan="1">75,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Phenobarbital</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Phenytoin</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Primidone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Procyclidine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Propoxyphene</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Secobarbital</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Tapentadol</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Temazepam</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Triprolidine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Valproic Acid</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Venlafaxine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Verapamil</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr></table>

When Carbamazepine was added to near cutoff negative ( $2 2 5 ~ \mathrm { n g / m L }$ samples at concentrations of $4 { , } 0 0 0 \ \mathrm { n g / m L }$ in serum, positive results were observed. Device labeling includes the following limitation: “Patient samples containing tricyclic antidepressants in the presence of carbamazepine may yield falsely elevated results in the TCA immunoassay. Results should always be assessed in conjunction with the patient’s medical history, clinical examinations, and other clinicopathological findings.”

Interference Testing of exogenous and endogenous compounds Interference from various compounds was evaluated by adding known amounts of each compound to drug free serum and urine samples containing near cutoff negative $( 2 2 5 \mathrm { n g / m L } )$ ) and near cutoff positive $3 7 5 \mathrm { n g / m L } )$ concentrations of Nortriptyline. Testing was performed in both qualitative and semiquantitative modes. The compounds listed in the table below did not cause any positive or negative interference at the concentrations shown:

Table #10: Interference Test of structurally unrelated compounds - Serum   

<table><tr><td rowspan=1 colspan=1>Compounds</td><td rowspan=1 colspan=1>Tested Concentration (mg/dL)</td></tr><tr><td rowspan=1 colspan=1>Bilirubin (Conjugated)</td><td rowspan=1 colspan=1>40</td></tr><tr><td rowspan=1 colspan=1>Bilirubin (Unconjugated)</td><td rowspan=1 colspan=1>40</td></tr><tr><td rowspan=1 colspan=1>Hemoglobin</td><td rowspan=1 colspan=1>1000</td></tr><tr><td rowspan=1 colspan=1>Albumin</td><td rowspan=1 colspan=1>7500</td></tr><tr><td rowspan=1 colspan=1>γ-globulin</td><td rowspan=1 colspan=1>5000</td></tr><tr><td rowspan=1 colspan=1>Rh Factor</td><td rowspan=1 colspan=1>1300IU</td></tr><tr><td rowspan=1 colspan=1>Triglycerides</td><td rowspan=1 colspan=1>1500</td></tr><tr><td rowspan=1 colspan=1>Cholesterol</td><td rowspan=1 colspan=1>1400</td></tr></table>

Table #11: Interference Test of structurally unrelated compounds – Urine   

<table><tr><td rowspan=1 colspan=1>Compounds</td><td rowspan=1 colspan=1>Test Concentration (mg/dL)</td></tr><tr><td rowspan=1 colspan=1>Ascorbic Acid</td><td rowspan=1 colspan=1>150</td></tr><tr><td rowspan=1 colspan=1>Caffeine</td><td rowspan=1 colspan=1>5</td></tr><tr><td rowspan=1 colspan=1>Creatinine</td><td rowspan=1 colspan=1>400</td></tr><tr><td rowspan=1 colspan=1>Ethanol</td><td rowspan=1 colspan=1>1000</td></tr><tr><td rowspan=1 colspan=1>Galactose</td><td rowspan=1 colspan=1>5</td></tr><tr><td rowspan=1 colspan=1>Glucose</td><td rowspan=1 colspan=1>1000</td></tr><tr><td rowspan=1 colspan=1>Hemoglobin</td><td rowspan=1 colspan=1>150</td></tr><tr><td rowspan=1 colspan=1>Human Serum Albumin</td><td rowspan=1 colspan=1>200</td></tr><tr><td rowspan=1 colspan=1>Ibuprofen</td><td rowspan=1 colspan=1>10</td></tr><tr><td rowspan=1 colspan=1>Oxalic acid</td><td rowspan=1 colspan=1>50</td></tr><tr><td rowspan=1 colspan=1>Riboflavin</td><td rowspan=1 colspan=1>3</td></tr><tr><td rowspan=1 colspan=1>Sodium Chloride</td><td rowspan=1 colspan=1>1000</td></tr><tr><td rowspan=1 colspan=1>Urea</td><td rowspan=1 colspan=1>1000</td></tr></table>

# Interference Testing of Specific Gravity and pH (Urine):

Drug free urine samples with specific gravity ranging in value from 1.004 to 1.030 were split and spiked with Nortriptyline to near cutoff negative $( 2 2 5 \mathrm { n g / m L } )$ and near cutoff positive $( 3 7 5 ~ \mathrm { n g / m L } )$ concentrations. Samples were evaluated in qualitative and semi-quantitative modes. The following specific gravities did not cause any positive or negative interference:

Interference from $\mathsf { p H }$ was evaluated by adjusting the $\mathsf { p H }$ of urine samples containing near cutoff negative $( 2 2 5 ~ \mathrm { n g / m L } )$ and near cutoff positive $3 7 5 \mathrm { n g / m L }$ concentrations of Nortriptyline. The following $\mathsf { p H }$ values did not cause any positive or negative interference: 3, 4, 5, 6, 7, 8, 9, 10 and 11.

4. Assay Reportable Range: Not applicable.

5. Traceability, Stability, Expected Values (Controls, Calibrators, or Methods):

Traceability: The primary calibrators are traceable to the certified reference material Nortriptyline purchased from a commercial source. The concentration of the primary calibrator stocks is confirmed by LC-MS/MS from independent laboratories.

6. Detection Limit: Not applicable.

7. Assay Cut-Off:

Characterization of how the device performs analytically around the claimed cutoff concentration is described in the precision section, VII.A.1. above.

# B Comparison Studies:

# 1. Method Comparison with Predicate Device:

One hundred seventeen serum clinical specimens and one hundred urine clinical specimens were tested using the DRI™ Tricyclics Serum Tox Assay on the Architect c4000 clinical chemistry analyzer and confirmed by LC-MS/MS. The results are presented below:

Table #12: Qualitative Accuracy Study with LC-MS/MS as Reference Method – Serum   

<table><tr><td colspan="1" rowspan="1">Candidate DeviceNegative byResults</td><td colspan="1" rowspan="1">LC-MS/MS</td><td colspan="1" rowspan="1">&lt; 50% ofCutoffconcentrationby LC-MS/MS (&lt;150 ng/mL)</td><td colspan="1" rowspan="1">Near CutoffNegative(Between 50%below the cutoffand the cutoffconcentration asdetermined byLC-MS/MS)(150-299 ng/mL)</td><td colspan="1" rowspan="1">Near CutoffPositive(Between thecutoff and 50%above the cutoffconcentration)concentration as (&gt; 450 ng/mL)determined byLC-MS/MS)(300-450ng/mL)</td><td colspan="1" rowspan="1">High Positives(Greater than50% abovecutoffabove the cutoffconcentration)concentration as (&gt; 450 ng/mL)</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">31</td><td colspan="1" rowspan="1">25</td></tr><tr><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">35</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">CandidateDeviceResults</td><td colspan="1" rowspan="1">Negative byLC-MS/MS</td><td colspan="1" rowspan="1">&lt; 50% ofCutoffconcentrationby LC-MS/MS (&lt;150 ng/mL)</td><td colspan="1" rowspan="1">Near CutoffNegative(Between 50%below the cutoffand the cutoffconcentration asdetermined byLC-MS/MS)(150-299 ng/mL)</td><td colspan="1" rowspan="1">Near CutoffPositive(Between thecutoff and 50%above the cutoffconcentration asdetermined byLC-MS/MS)(300-450 ng/mL)</td><td colspan="1" rowspan="1">High Positives(Greater than50% above cutoffconcentration)(&gt; 450ng/mL)</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">42</td></tr><tr><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td></tr></table>

Table #14: Semi-quantitative Accuracy Study with LC-MS/MS as Reference Method - Serum   

<table><tr><td rowspan=2 colspan=1>CandidateDeviceResults</td><td rowspan=2 colspan=1>Negative byLC-MS/MS</td><td rowspan=1 colspan=1>&lt; 50% ofCutoff</td><td rowspan=2 colspan=1>Near CutoffNegative(Between 50%below the cutoffand the cutoffconcentration asdetermined by LC-MS/MS)(150-299ng/mL)</td><td rowspan=2 colspan=1>Near CutoffPositive(Between thecutoff and 50%above the cutoffconcentration asdetermined byLC-MS/MS)(300-450ng/mL)</td><td rowspan=2 colspan=1>High Positives(Greater than50% above cutoffconcentration)(&gt; 450ng/mL)</td></tr><tr><td rowspan=1 colspan=1>concentrationby LC-MS/MS (&lt;150 ng/mL)</td></tr><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>31</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>34</td><td rowspan=1 colspan=1>24</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

Table #15: Semi-quantitative Accuracy Study with LC-MS/MS as Reference Method - Urine   

<table><tr><td rowspan=1 colspan=1>CandidateDeviceResults</td><td rowspan=1 colspan=1>Negative byLC-MS/MS</td><td rowspan=1 colspan=1>&lt; 50% ofCutoffconcentrationby LC-MS/MS (&lt;150 ng/mL)</td><td rowspan=1 colspan=1>Near CutoffNegative (Between50% below thecutoff and thecutoffconcentration asdetermined by LC-MS/MS) (150-299ng/mL)</td><td rowspan=1 colspan=1>Near CutoffPositive(Between thecutoff and 50%above the cutoffconcentration asdetermined byLC-MS/MS)(300-450 ng/mL)</td><td rowspan=1 colspan=1>High Positives(Greater than50% above cutoffconcentration)(&gt; 450 ng/mL)</td></tr><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>42</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr></table>

Table #16: Discordant Samples:   

<table><tr><td rowspan=2 colspan=1>Sample ID</td><td rowspan=2 colspan=1>Sample Type</td><td rowspan=1 colspan=2>EIA</td><td rowspan=2 colspan=1>LC-MS/MS value (ng/ml)</td></tr><tr><td rowspan=1 colspan=1>Qualitative</td><td rowspan=1 colspan=1>Semi-Quantitative</td></tr><tr><td rowspan=1 colspan=1>APP9489-22</td><td rowspan=1 colspan=1>Serum</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>110</td></tr><tr><td rowspan=1 colspan=1>APP9474-21,2</td><td rowspan=1 colspan=1>Serum</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>120</td></tr></table>

Sample APP9489-2 contains the following parent Tricyclic antidepressants: Amitriptyline at $8 . { \bar { 0 } } 8 ~ \mathrm { { n g / m L } }$ , Imipramine at $1 8 . 3 5 \mathrm { n g / m L }$ , Desipramine at $4 6 . 3 5 \mathrm { \bar { n g / m L } }$ , and Nortriptyline at $1 7 \mathrm { \bar { n g } / m L }$ by LC-MS/MS which cross-react at $100 \%$ , $1 5 8 \%$ $120 \%$ and $100 \%$ respectively by immunoassay. In addition to the tricyclic antidepressants identified, another cross-reacting drug compound was detected in the sample, as below:

<table><tr><td rowspan=1 colspan=1>Drug Class</td><td rowspan=1 colspan=1>Drug Name</td><td rowspan=1 colspan=1>LC-MS/MS value (ng/mL)</td></tr><tr><td rowspan=1 colspan=1>Antiepileptic drugs</td><td rowspan=1 colspan=1>Carbamazepine</td><td rowspan=1 colspan=1>4275</td></tr></table>

Sample APP9474-2 contains Amitriptyline at $9 . 0 8 ~ \mathrm { n g / m L }$ , Imipramine at $1 9 . 9 \mathrm { n g / m L }$ and Desipramine at $4 9 . 8 ~ \mathrm { n g / m L }$ , and Nortriptyline at $1 9 . 6 5 ~ \mathrm { n g / m L }$ by LC-MS/MS and crossreacts at $100 \%$ , $1 5 8 \%$ $120 \%$ , and $100 \%$ by immunoassay accordingly. In addition to the tricyclic antidepressants identified, another cross-reacting drug compound was detected in the sample, as below:

<table><tr><td rowspan=1 colspan=1>Drug Class</td><td rowspan=1 colspan=1>Drug Name</td><td rowspan=1 colspan=1>LC-MS/MS value (ng/mL)</td></tr><tr><td rowspan=1 colspan=1>Antiepileptic drugs</td><td rowspan=1 colspan=1>Carbamazepine</td><td rowspan=1 colspan=1>5285</td></tr></table>

# 2. Matrix Comparison:

50 Patient specimens were run in both qualitative and semi-quantitative modes. The testing specimens consisted of matched sets of; Serum, K2-EDTA, K3-EDTA, Lithium Heparin, Sodium Citrate, Potassium Oxalate samples; as well as 45 secondary matched sets of Serum and Sodium Heparin samples. The Nortriptyline concentrations of the samples tested spanned from approximately $1 3 5 \mathrm { n g / m L }$ to approximately $9 3 0 ~ \mathrm { n g / m L }$ . The study demonstrates Nortriptyline concentrations obtained in different test plasma matrices with different anticoagulants are equivalent to those measured in the primary or control matrix, serum across the assay’s measuring range.

Table #17: Matrix Equivalency results in qualitative and semi-quantitative mode   

<table><tr><td rowspan=2 colspan=2>Serum Matrix</td><td rowspan=1 colspan=2>Qualitative</td><td rowspan=1 colspan=2>Semi- Quantitative</td></tr><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=2 colspan=1>K2 EDTA Plasma</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=2 colspan=1>K3 EDTA plasma</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=2 colspan=1>Lithium Heparin Plasma</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=2 colspan=1>Sodium Citrate Plasma</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=2 colspan=1>Potassium Oxalate Plasma</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=2 colspan=1>Sodium Heparin Plasma</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td></tr></table>

# C Clinical Studies:

1. Clinical Sensitivity: Not applicable.

2. Clinical Specificity: Not applicable.

3. Other Clinical Supportive Data (When 1. and 2. Are Not Applicable): Not applicable.

# D Clinical Cut-Off:

Not applicable.

# E Expected Values/Reference Range:

# Qualitative results

A sample that exhibits a change in absorbance $( \Delta \mathrm { A } )$ value equal to or greater than the cutoff calibrator is considered positive. A sample that exhibits a change in absorbance $( \Delta \mathrm { A } )$ value lower than the cutoff calibrator is considered negative.

# Semiquantitative results

A rough estimate of drug concentration in the samples can be obtained by running a standard curve with all calibrators and measuring samples off the standard curve.

Immunoassays that produce only a single result in the presence of a class of drugs such as Tricyclic Antidepressants (TCAs) cannot accurately measure the concentration of each individual component. For a qualitative application, a positive result indicates only the presence of TCAs. For a semiquantitative application, the assay gives an approximate, cumulative concentration of TCAs.

# VIII Proposed Labeling:

The labeling supports the finding of substantial equivalence for this device.

# IX Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.